awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36438481-A8E21846-220C-4825-8AAC-1964EB0FCC71
Q36438481-A8E21846-220C-4825-8AAC-1964EB0FCC71
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36438481-A8E21846-220C-4825-8AAC-1964EB0FCC71
Antibodies for targeted cancer therapy -- technical aspects and clinical perspectives.
P2860
Q36438481-A8E21846-220C-4825-8AAC-1964EB0FCC71
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36438481-A8E21846-220C-4825-8AAC-1964EB0FCC71
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8eed6da0086dbaf03df1ef802c00118d4e4f44e3
P2860
Cross-linking of the CAMPATH-1 antigen (CD52) mediates growth inhibition in human B- and T-lymphoma cell lines, and subsequent emergence of CD52-deficient cells.